TY - JOUR
T1 - Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery
T2 - An International Randomized Controlled Trial
AU - Marcucci, Maura
AU - Painter, Thomas W.
AU - Conen, David
AU - Lomivorotov, Vladimir
AU - Sessler, Daniel I.
AU - Chan, Matthew T.V.
AU - Borges, Flavia K.
AU - Leslie, Kate
AU - Duceppe, Emmanuelle
AU - Martínez-Zapata, María José
AU - Wang, Chew Yin
AU - Xavier, Denis
AU - Ofori, Sandra N.
AU - Wang, Michael Ke
AU - Efremov, Sergey
AU - Landoni, Giovanni
AU - Kleinlugtenbelt, Ydo V.
AU - Szczeklik, Wojciech
AU - Schmartz, Denis
AU - Garg, Amit X.
AU - Short, Timothy G.
AU - Wittmann, Maria
AU - Meyhoff, Christian S.
AU - Amir, Mohammed
AU - Torres, David
AU - Patel, Ameen
AU - Ruetzler, Kurt
AU - Parlow, Joel L.
AU - Tandon, Vikas
AU - Fleischmann, Edith
AU - Polanczyk, Carisi A.
AU - Lamy, Andre
AU - Jayaram, Raja
AU - Astrakov, Sergey V.
AU - Wu, William Ka Kei
AU - Cheong, Chao Chia
AU - Ayad, Sabry
AU - Kirov, Mikhail
AU - de Nadal, Miriam
AU - Likhvantsev, Valery V.
AU - Paniagua, Pilar
AU - Aguado, Hector J.
AU - Maheshwari, Kamal
AU - Whitlock, Richard P.
AU - McGillion, Michael H.
AU - Vincent, Jessica
AU - Copland, Ingrid
AU - Balasubramanian, Kumar
AU - Biccard, Bruce M.
AU - Srinathan, Sadeesh
AU - POISE-3 Trial Investigators and Study Groups
N1 - Funding Information:
Financial Support: By Canadian Institutes of Health Research Foundation Grant awarded to Dr. Devereaux (FDN-143302); National Health and Medical Research Council, Funding Schemes, NHMRC Project Grant 1162362; and General Research Fund 14104419, Research Grant Council, Hong Kong SAR, China. POISE-3 also received financial support from the Population Health Research Institute and the Hamilton Health Science Research Institute, and an investigator-initiated study grant from Roche Diagnostics International.
Funding Information:
Primary Funding Source: Canadian Institutes of Health Research, National Health and Medical Research Council (Australia), and Research Grant Council of Hong Kong.
Publisher Copyright:
© 2023 American College of Physicians.
PY - 2023
Y1 - 2023
N2 - Background: Among patients having noncardiac surgery, perioperative hemodynamic abnormalities are associated with vascular complications. Uncertainty remains about what intraoperative blood pressure to target and how to manage long-term antihypertensive medications perioperatively. Objective: To compare the effects of a hypotension-avoidance and a hypertension-avoidance strategy on major vascular complications after noncardiac surgery. Design: Partial factorial randomized trial of 2 perioperative blood pressure management strategies (reported here) and tranexamic acid versus placebo. (ClinicalTrials.gov: NCT03505723) Setting: 110 hospitals in 22 countries. Patients: 7490 patients having noncardiac surgery who were at risk for vascular complications and were receiving 1 or more long-term antihypertensive medications. Intervention: In the hypotension-avoidance strategy group, the intraoperative mean arterial pressure target was 80 mm Hg or greater; before and for 2 days after surgery, renin–angiotensin–aldosterone system inhibitors were withheld and the other long-term antihypertensive medications were administered only for systolic blood pressures 130 mm Hg or greater, following an algorithm. In the hypertension-avoidance strategy group, the intraoperative mean arterial pressure target was 60 mm Hg or greater; all antihypertensive medications were continued before and after surgery. Measurements: The primary outcome was a composite of vascular death and nonfatal myocardial injury after noncardiac surgery, stroke, and cardiac arrest at 30 days. Outcome adjudicators were masked to treatment assignment. Results: The primary outcome occurred in 520 of 3742 patients (13.9%) in the hypotension-avoidance group and in 524 of 3748 patients (14.0%) in the hypertension-avoidance group (hazard ratio, 0.99 [95% CI, 0.88 to 1.12]; P = 0.92). Results were consistent for patients who used 1 or more than 1 antihypertensive medication in the long term. Limitation: Adherence to the assigned strategies was suboptimal; however, results were consistent across different adherence levels. Conclusion: In patients having noncardiac surgery, our hypotension-avoidance and hypertension-avoidance strategies resulted in a similar incidence of major vascular complications.
AB - Background: Among patients having noncardiac surgery, perioperative hemodynamic abnormalities are associated with vascular complications. Uncertainty remains about what intraoperative blood pressure to target and how to manage long-term antihypertensive medications perioperatively. Objective: To compare the effects of a hypotension-avoidance and a hypertension-avoidance strategy on major vascular complications after noncardiac surgery. Design: Partial factorial randomized trial of 2 perioperative blood pressure management strategies (reported here) and tranexamic acid versus placebo. (ClinicalTrials.gov: NCT03505723) Setting: 110 hospitals in 22 countries. Patients: 7490 patients having noncardiac surgery who were at risk for vascular complications and were receiving 1 or more long-term antihypertensive medications. Intervention: In the hypotension-avoidance strategy group, the intraoperative mean arterial pressure target was 80 mm Hg or greater; before and for 2 days after surgery, renin–angiotensin–aldosterone system inhibitors were withheld and the other long-term antihypertensive medications were administered only for systolic blood pressures 130 mm Hg or greater, following an algorithm. In the hypertension-avoidance strategy group, the intraoperative mean arterial pressure target was 60 mm Hg or greater; all antihypertensive medications were continued before and after surgery. Measurements: The primary outcome was a composite of vascular death and nonfatal myocardial injury after noncardiac surgery, stroke, and cardiac arrest at 30 days. Outcome adjudicators were masked to treatment assignment. Results: The primary outcome occurred in 520 of 3742 patients (13.9%) in the hypotension-avoidance group and in 524 of 3748 patients (14.0%) in the hypertension-avoidance group (hazard ratio, 0.99 [95% CI, 0.88 to 1.12]; P = 0.92). Results were consistent for patients who used 1 or more than 1 antihypertensive medication in the long term. Limitation: Adherence to the assigned strategies was suboptimal; however, results were consistent across different adherence levels. Conclusion: In patients having noncardiac surgery, our hypotension-avoidance and hypertension-avoidance strategies resulted in a similar incidence of major vascular complications.
U2 - 10.7326/M22-3157
DO - 10.7326/M22-3157
M3 - Journal article
C2 - 37094336
AN - SCOPUS:85159734603
VL - 176
SP - 605
EP - 614
JO - Annals of Internal Medicine
JF - Annals of Internal Medicine
SN - 0003-4819
IS - 5
ER -